RxDoctor Payments DataLook up a doctor →

Jane Raymond

Medical Oncology · Pittsburgh, PANPI 1518968825

Payments from drug & device makers

$793,656in general payments, 2019–2025

Across 911 payments — averaging $871.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$673K
  • Eli Lilly$76K
  • AstraZeneca$41K
  • Genentech, Inc.$2K
  • Genentech USA, Inc.$406
  • Lilly USA, LLC$98
  • plus $133 from 7 others
$6,119in research payments, 2019–2025

Across 4 payments — averaging $1529.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6K

What the payments were for

  • Travel & lodging$1,05349%
  • Food & beverage$1,09551%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$793,656 in reported general payments places this provider in the 75th percentile of 238 medical oncology providers in Pennsylvania.

See all medical oncology providers in Pennsylvania

Other medical oncology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →